Humbl Inc (OTCMKTS: HMBL) continues to move steadily northbound since reversing off $0.075 lows on May 11. Since than HMBL has been under heavy accumulation and recently surpassed a dime as the stock continues to make ground. HMBL looks cheap for a stock that was the biggest runner of 2020 skyrocketing from sub pennies starting as TSNP and running to multi dollars as HMBL at one point achieving a market cap of $1 billion dollars plus hitting highs of $7.72 post-split. HMBL has a massive following of investors behind and a major international following that continues to bid the price of HMBL higher. On Tuesday after the close, HMBL “Project: Search 3.” will go live as promised by the Company. “Search 3,” is one of the world’s first modular, blockchain-based Web 3 search engines. In addition to delivering traditional Web 2 search functionality such as web, videos, images and news, “Search 3” will also deliver cross-chain NFT search functionality across blockchain projects such as Ethereum, Solana, Gnosis, Polygon and BLOCKS.
HMBL is made up of team members from Company’s like Moneygram, Visa, Microsoft, Western Union American Express, Epson, Qualcomm and Facebook and was named a Forbes “Rising Startups to Watch” in June 2020. The Company has a powerful management team behind it led by CEO Brian Foote. Recently they brought back stock whizz George Sharp as Capital Markets Advisor who is shepherding HUMBL through the application process to the NASDAQ Stock Market since achieving fully reporting OTCQB tier in January of this year. There are currently a number of class action lawsuits filed against HMBL over the past week, they allege that Defendants violated provisions of the Exchange Act by making false and misleading statements concerning the Company’s growth prospects, technological advancements, international partnerships, and financial benefits. So far, the lawsuits have had no effect on HMBL which continues to rise.The Company has made major moves in the NFT space, to find out more on that read our previous articles on Humbl.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Humbl Inc (OTCMKTS: HMBL) is a new, Web 3 platform being developed to seamlessly connect consumers and merchants in the digital economy, across its HUMBL Mobile Applications, HUMBL Marketplace and HUMBL Financial divisions. HUMBL Mobile Applications will deliver more seamless global transactions, by integrating multiple currencies, payment methods and financial services into reduced clicks for the customer. HUMBL Marketplace was developed to connect customers and merchants online, in improved global commerce, deal discovery and blockchain tokenization programs. HUMBL Financial has developed new software and algorithms for the digital asset trading markets, which are a new global market for blockchain technologies, and will also offer other credit, lending and financial services. Current enterprise tech partners of Humblpay include Datarobot, UIPath, Trulioo, Acuant, Sovrin, identify for all, Indicio tech, Cisco, Good Health Pass, The Commons Project, AWS and Smart. HMBL went public via a reverse merger with TSNP the biggest runner of 2020 before changing its name to HUMBL.
Since going public via the RM with TSNP HUMBL has made a number of acquisitions including Tickeri, a leading ticketing, live events and box office SaaS platform featuring Latin events and artists throughout the United States, Latin America, and the Caribbean corridor. HUMBLE also acquired Monster Creative, LLC; a Hollywood production studio that specializes in producing movie trailers and other related content. On December 21, Monster Creative reported it has won two awards at the 2021 Clio Awards, as well as one nomination. In February the Company acquired the mobile identification, verifiable credentials and blockchain tokenization platform of BizSecure, as well as its employee and consulting resources. With this extensive acquisition, HUMBL will form a new commercial division called HUMBL Blockchain Services™, which will introduce and deliver blockchain corporate and governmental solutions. They also acquired Ixaya Business SA de CV, a Mexico-based firm with over 15 years of experience in developing software and IT solutions for the automotive, banking, payments, financial services, oil and gas, real estate, and cybersecurity sectors. With this acquisition, HUMBL gained direct access to more than thirty-five (35) Ixaya technology team members specializing in product design, front-end engineering, back-end engineering, dev ops and blockchain development.
HMBL initially launched “Project: Search 3.” earlier this year. The initiative will result in the production of “Search 3,” one of the world’s first modular, blockchain-based Web 3 search engines. The company announced that it is already well underway on the building of the technology, which is expected to ship to the global markets sometime in the first half of calendar year 2022.
In addition to delivering traditional Web 2 search functionality such as web, videos, images and news, “Search 3” will also deliver cross-chain NFT search functionality across blockchain projects such as Ethereum, Solana, Gnosis, Polygon and BLOCKS. The search engine will also make available “Verified by BLOCKS” technology, an additional layer of metadata, storage and authentication that can be applied to both physical supply chain and digital objects, such as NFTs. As part of the launch, HUMBL has acquired the domain name Search3.com, where it plans to host its “Search 3” consumer search engine. The company is in the process of filing a “Search 3” technology patent and has already filed for a trademark on the term “Search 3.” Project: Search 3” is being spearheaded by the newly formed HUMBL Blockchain Services (HBS), in conjunction with Ixaya, HUMBL’s newly acquired thirty-five (35) person technology accelerator in Leon, Mexico, as well as internal HUMBL technology teams.
Episode 1 of "HUMBL: Blocks Talks" will be out this week. We covered building a full #Web3 stack:
Also, in April HMBL launched its BLOCK Exchange Traded Index (ETXs) to United States customers beginning on April 2, 2021. HUMBL Financial™ created its BLOCK ETX products to simplify digital asset investing for customers and institutions seeking exposure to a new, 24/7 digital asset class. The Company has developed proprietary, multi-factor blockchain indexes, trading algorithms and financial services for the new digital asset trading markets. BLOCK ETXs comprise over 20,000 lines of proprietary code and are architected across index, active and thematic investment strategies. This is a completely non-custodial, algorithmically driven software services that allow customers to purchase and hold digital assets in pre-set allocations through their own digital asset exchange accounts. BLOCK ETXs are compatible for United States customers who have accounts with Coinbase Pro, Bittrex US or Binance US. and international customers who have accounts with Bittrex Global.
13 class action lawsuits have been filed against HMBL over the past week, they allege that:
The complaint(s) allege that Defendants violated provisions of the Exchange Act by making false and misleading statements concerning the Company’s growth prospects, technological advancements, international partnerships, and financial benefits for Humbl common stock and digital asset investors, as well as using selectively timed announcements to keep Humbl stock price high so that Company insiders could sell off their holdings into artificially created volume. The complaint also alleges that Defendants violated provisions of the Securities Act by selling its unregistered securities (BLOCK ETX digital assets) to investors.
Earlier in May HMBL announced its CEO, Brian Foote has contributed 100 million BLOCKS to the HUMBL balance sheet for use in blockchain pilot programs, employee compensation and more. BLOCKS were created as hybrid Web 3 tokens that can accommodate a variety of blockchain use cases and tokenized pilot tests, ranging from mobile wallets, verifiable credentials, NFT verification, DAO management and more. BLOCKS will be recorded as an asset on the HUMBL balance sheet, with an approximate fiat currency value of $700,000 (USD) as of 6:00 AM PST on May 16, 2022.
On May 25 HMBL announced it has completed the integration of the Polygon sidechain into HUMBL’s NFT platform, which will help creators more easily deliver NFTs to their collectors while reducing gas fees and minting costs. As a Layer 2 solution built on Ethereum, the Polygon sidechain allows users to conduct most transactions on the Ethereum blockchain for, in most cases, a fraction of the cost, and with greater speed than the Ethereum mainchain.
NFTs are unique non-fungible, cryptographic tokens that reside on a blockchain which cannot be replicated, enabling creators to tokenize their intellectual property or work product so that it can be bought, sold and traded in new ways on the blockchain. The HUMBL NFT platform is accessible at HUMBL.com, and will also integrate its technologies over time into HUMBL’s “Search 3” Search Engine, which is launching on May 31, 2022 at Search3.com.
Q1 2022 – Highlights
– Revenue up approx. 644% vs. Q1 2021 of last year – Revenue up approx. 24% vs. Q4 2021 of last year – Over 63% of company's expenses were non-cash charges – Acquired BizSecure and Ixaya contracts, technologies and teams#HUMBLhttps://t.co/fZjtQUvgsKpic.twitter.com/yR6HUNF7Zm
Currently trading at a $147 million market valuation HMBL is on the move northbound as the Company will takes“Project: Search 3.” live after the close. “Search 3,” is one of the world’s first modular, blockchain-based Web 3 search engines. In addition to delivering traditional Web 2 search functionality such as web, videos, images and news, “Search 3” will also deliver cross-chain NFT search functionality across blockchain projects such as Ethereum, Solana, Gnosis, Polygon and BLOCKS. HMBL is easily one of the most exciting stocks in small caps, it was the biggest reverse merger of 2020 and the biggest runner of 2020 skyrocketing from sub pennies starting as TSNP and running to multi dollars as HMBL at one point achieving a market cap of $1 billion dollars plus hitting highs of $7.72 post-split. HMBL has a massive following of investors behind it and can run quick, the stock is a volume leader on the OTC and regularly among the top most traded stocks on the OTCQB exchange. Currently trading surpassing a dime since reversing off $0.075 the lawsuits have had little effect if any so far. Like any penny stock HMBL has plenty of risks, but HMBL has runner in its blood and has a massive gap to fill, it’s got the biggest audience on the OTCQB who are accumulating now as the stock has made a definitive reversal northbound.Microcapdaily was first on the scene when TSNP started running reporting on the stock on November 15, 2020 when the stock was around $0.003.We will be updating on HMBL when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with HMBL.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in HMBL either long or short and we have not been compensated for this article.
On August 8th, 2023, Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a leading developer in the psychedelic drug industry, witnessed an impressive surge in its stock value, gaining approximately 25% in combined trading, including after-hours (AH) trading. The British Columbia-based company made headlines by announcing its strategic move to acquire intellectual property (IP) from the renowned cannabis publication, High Times Holding Corp. (HHC).
Additional Background:
Under this agreement, Lucy will exchange 20% of its shares and a series of payments for access to HHC’s valuable IP portfolio, which includes the rights to generate licensing and royalty income from renowned brands like High Times, 420.com, and Cannabis Cup, along with their associated domain names.
Lucy’s commitment involves making semi-annual payments to HHC over a five-year period, structured around earnings before income, taxes, depreciation, and amortization (EBITDA) generated through the acquired IP. The flexibility exists for Lucy to fulfill these payments either in cash or through stock issuance and the announcement is generating considerable interest.
Furthermore, post-acquisition, Lucy will grant High Times the opportunity to operate retail outlets and distribute THC products bearing these prestigious brands within the United States. This privilege comes in exchange for an annual license fee of $1 million, set to double to $2 million annually once federal legalization of cannabis occurs in the country.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Leveraging the brand rights secured from HHC, Lucy aims to bolster its revenue streams by expanding and enhancing its existing 18 licensing agreements, both domestically and internationally. These arrangements encompass a wide array of consumer products and merchandise, promising to further establish Lucy’s presence in the global market. The acquisition is expected to be finalized within the coming two weeks, marking a significant strategic move for Lucy Scientific Discovery Inc.
As a result of the acquisition, High Times is now a publicly-traded entity. Lucy anticipates that this agreement will contribute over $10 million in revenue to its financial results in the upcoming year, along with $5 million in EBITDA.
Adam Levin, the Executive Chairman of HHC, expressed optimism about the deal, noting, “This transaction will create exciting new growth opportunities for the High Times brand, under the leadership of Richard Nanula, a seasoned executive with extensive experience in major consumer brands and global corporations.”
Levin also emphasized High Times’ enthusiasm in becoming a significant shareholder of Lucy Scientific Discovery. Notably, Lucy completed its initial public offering and Nasdaq listing in February, offering 1,875,000 shares at $4.00 each.
Richard Nanula, CEO of the British Columbia-based company, shared his outlook on the acquisition, stating, “Lucy expects this acquisition to rapidly generate high-margin revenue within the global cannabis sector.”
In recent developments, Lucy introduced the sleep aid product “Twilight,” which includes amanita muscaria and reishi mushrooms. Additionally, the company joined forces with Wesana Health Holdings Inc. (OTCQB: WSNAF) in March to collaborate on the development of the CBD and psilocybin-based drug SANA-013, targeting conditions such as migraines, cluster headaches, and major depressive disorder.
$LSDI's Health Canada license allows approved psilocybin sales, backed by the Canadian government's significant funding $LSDI is on fire. #LucyScientificDiscovery$LSDI
High Times, founded in 1974, has a rich history, featuring works by renowned writers like Truman Capote and Hunter S. Thompson. Since 1988, its Cannabis Cup has stood as the most prestigious cannabis competition globally, with notable judges including Snoop Dogg, Joe Rogan, Tommy Chong, and other prominent figures in the cannabis industry.
While Lucy’s shares showed a nearly 16% increase to reach $0.68 on the Nasdaq exchange on Friday, it is worth noting that they have experienced a decline of over 77% over the past year.
Macro Trend:
In recent times, our articles have prominently featured cannabis-related topics, reflecting the growing popularity of stocks in this sector. LSDI’s acquisition aligns perfectly with the current climate, as the cannabis industry experiences a significant surge, coinciding with the Health and Human Services (HHS) exploring the possibility of reclassifying cannabis from Schedule I to Schedule III of the Controlled Substances Act.
While many countries around the world have already moved towards decriminalization and legalization, the United States has been relatively cautious in its approach. However, the consideration of such a reclassification represents a potential historic turning point. If such a change were to materialize, it would mark a substantial shift in the regulatory landscape, potentially revitalizing cannabis as an attractive investment opportunity. The industry is already showing signs of reestablishing its market presence and could once again become a noteworthy investment option.
We will update you on LSDI when more details emerge, subscribe to Microcapdaily to follow along!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
WM Technology’s (NASDAQ: MAPS) stock has exhibited remarkable growth, surging by an impressive 91% since August 16th, 2023. Intriguingly, this surge occurred in the absence of any substantial news or filings from the company, with their most recent release dating back to August 23rd, 2023. This limited information raises the question: What is driving this impressive rally? We will delve into the details below to shed light on the matter.
Cannabis Industry:
If you’ve been following our newsletter, you may have noticed our recent article spotlighting Flora Growth Corp. (NASDAQ: FLGC), along with larger players like Cronos Group Inc. (NASDAQ: CRON), and Canopy Growth Corporation (NASDAQ: CGC).
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
In case you haven’t had a chance to read it, you can find the article here, featuring a dedicated section on the broader trends shaping the cannabis industry.
For those seeking a quick summary, a significant development has emerged in the cannabis landscape. A high-ranking official at the Department of Health and Human Services (HHS) has proposed moving cannabis from Schedule I to Schedule III of the Controlled Substances Act. This shift marks a historic moment and comes after a comprehensive yearlong investigation requested by President Biden.
It’s worth noting the potential implications of this change for U.S.-based, plant-touching marijuana companies. Currently, these companies are restricted from trading on major exchanges like the NYSE or NASDAQ and are relegated to smaller markets such as the OTC, or smaller Canadian markets like the TSX, CSE, or NEO.
The CEO of Trulieve Cannabis Corp. (OTC: TCNNF), Kim Rivers delves into these implications in a podcast conversation with a Twitter user known as @stock_mj. She also recommends keeping a close eye on the AdvisorShares Pure US Cannabis ETF (MSOS) as the cannabis sector garners increasing attention from investors.
According to Kim Rivers on Spaces, the NASDAQ is currently going through regulatory policy to check if a Schedule 3 move would allow for uplisting.
To evaluate the potential of MAPS, it’s essential to examine their recent earnings and assess the fundamentals. Here’s a brief overview of the news release.
Revenue: Amounted to $50.9 million, representing a decline compared to the same period in the prior year when it reached $58.3 million.
Net Income: Recorded at $2.0 million for the second quarter of 2023, marking a significant decrease from the previous year’s figure of $19.8 million.
Adjusted EBITDA: Showed substantial improvement, totaling $10.2 million in the second quarter of 2023, as opposed to a negative figure of $(0.6) million in the same period of the prior year.
Cash: As of June 30, 2023, the company held $24.6 million in cash, noteworthy for being entirely debt-free.
WM Technology’s Executive Chair, Doug Francis, underscored the company’s dedication to reinforcing its financial position and delivering sustained growth.
Guidance for the third quarter of 2023:
Revenue: An estimated $47 million.
Non-GAAP Adjusted EBITDA: Approximately $4 million.
It’s important to note that these projections are subject to potential variations based on various factors and developments.
Furthermore, WM Technology announced the transition to Moss Adams LLP as its new independent registered public accounting firm, effective upon the filing of the Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, following the resignation of Baker Tilly US, LLP due to staffing constraints.
Although the company maintains a debt-free status, it’s crucial to recognize that there has been a substantial decline in both revenue and net income. Consequently, it is advisable to exercise caution when considering investment, as the current trajectory of their top-line figures does not exhibit a positive trend.
Furthermore, the company made another recent announcement regarding its strategic partnership with the producer of “The Freak Brothers,” a celebrated stoner comic series that has captivated audiences for over five decades.
The series follows the adventures of three stoner characters and their cat, who awaken from a 50-year slumber induced by a magical strain of weed in 1969, now navigating life in contemporary San Francisco.
Key highlights of this partnership include in-episode Weedmaps integrations in the upcoming second half of “Freak Brothers” season two, commencing on September 24th. Additionally, exclusive “Smoke & Screen” events will be held across the U.S., bringing together influential figures from both the cannabis and entertainment industries.
“The Freak Brothers” series, based on Gilbert Shelton’s cult classic comic, celebrates its 55th anniversary with a star-studded voice cast for Season 2, featuring Woody Harrelson, John Goodman, Pete Davidson, Tiffany Haddish, Adam Devine, Blake Anderson, Andrea Savage, La La Anthony, ScHoolboy Q, and a special guest appearance by Joe Sikora.
To watch Season 2 of “The Freak Brothers,” visit Tubitv.com, and for cannabis-related information, explore Weedmaps.com. For more on “The Freak Brothers,” visit the official website at www.thefreakbrothers.com.
We will update you on MAPS when more details emerge, subscribe to Microcapdaily to follow along!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Flora Growth Corp. (NASDAQ: FLGC) experienced a remarkable intraday surge of over 77%. While the company has made significant announcements recently, today’s surge occurred without any specific filings or press releases to explain it. There seems to be something substantial driving this trading frenzy, a broader force impacting the entire asset class.
It’s worth noting that established industry leaders like Canopy Growth Corporation (NASDAQ: CGC) and Cronos Group Inc. (NASDAQ: CRON) have faced significant downtrends in past years. However, today’s market activity also lifted their stocks along with others. To understand this trend, let’s take a closer look at the larger market dynamics at play.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
What Happened:
A top official at the Department of Health and Human Services (HHS) has recommended moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, marking a historic shift. This move follows a comprehensive yearlong investigation requested by President Biden.
In the short term, this won’t significantly impact the cannabis industry, as the Drug Enforcement Agency (DEA) needs to conduct its own review and the federal prohibition on marijuana remains. However, the HHS recommendation, if followed by the DEA, could happen within a year, possibly before the 2024 presidential election.
Long-term implications for the cannabis industry are uncertain, but a key immediate effect would be the elimination of Section 280e of the IRS tax code for cannabis businesses. This provision currently prevents them from claiming standard business deductions, a major financial burden.
While rescheduling won’t directly open up access to institutional banking, it may attract new capital sources due to reduced risk perception among investors. Smaller banks and lenders might become more willing to engage.
Eliminating 280e could also stimulate lending in an industry with high borrowing costs, as companies would have improved cash flow. This might lead to lower interest rates and greater access to operating and expansion capital.
Rescheduling could benefit publicly traded cannabis companies, potentially enticing more exchanges, like the Toronto Stock Exchange, to accept U.S.-based cannabis businesses. It could also encourage Congress to take further action, such as passing the SAFE Banking Act and broader reforms.
Overall, while the exact implications of rescheduling are uncertain, the HHS announcement signals progress toward a post-prohibition reality for the cannabis industry, which is a significant development.
Having set the stage with the broader cannabis industry context, let’s delve into Flora Growth’s recent developments and their implications for the company’s future. Is Flora Growth strategically positioned to leverage the potential easing of restrictions in the cannabis sector?
European Expansion:
Flora Growth just formed a partnership with TruHC Pharma GmbH, a leading medical cannabis expert based in Hamburg, Germany. TruHC holds key certifications for importing, distributing, and manufacturing medical cannabis and is awaiting an EU-GMP license for its cutting-edge cannabis laboratory.
Hendrik Knopp, a respected legal professional and entrepreneur, and his team from TruHC are joining Flora, bringing their extensive expertise in pioneering medical cannabis in Germany. This partnership is seen as very valuable, especially as Germany and the European Union move towards making medical cannabis more accessible to patients.
Clifford Starke, CEO of Flora, expressed excitement about the collaboration, recognizing the potential to contribute to the growth of the medical cannabis industry as regulations evolve. The partnership aims to capture a significant market share in Germany.
Hulk Hogan Partnership:
Flora Growth also just recently entered an exclusive worldwide partnership with WWE legend Hulk Hogan to launch a range of consumer products through Just Brands. These products will include CBD-infused items like pre-rolls, topicals, edibles, and more, which Flora will produce and sell globally. The partnership aims to capitalize on Hulk Hogan’s iconic status and Flora’s global distribution network. The initial agreement is for three years, with potential renewals, targeting $20 million in sales over the first 24 months. Flora will pay royalties and license fees for Hulk Hogan-branded products.
Conclusion:
In summary, the cannabis industry appears ready for a resurgence, buoyed by renewed investor optimism and shifting market dynamics. Our focus today was Flora Growth Corp. (NASDAQ: FLGC) but larger names like Canopy Growth Corporation (NASDAQ: CGC) and Cronos Group Inc. (NASDAQ: CRON) are among the many companies benefitting from this positive trend.
We will update you on FLGC when more details emerge, subscribe to Microcapdaily to follow along!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.